Pfizer applies for Emergency Use Authorization of its vaccine in Philippines


American multinational pharmaceutical corporation Pfizer has applied for Emergency Use Authorization (EUA) of its COVID-19 vaccine in the Philippines, Presidential Spokesperson Secretary Harry Roque confirmed in a statement.

“Food and Drug Administration (FDA) Director-General Rolando Domingo confirmed that it filed for Emergency Use Authorization (EUA) last 23 December 2020,” Secretary Roque said.


“It will take FDA 21 days to evaluate and approve the EUA but vaccination would start as soon as stocks become available,” the presidential spokesperson added.